APA aipamena

Liu, H., Wei, P., Zhang, Q., Chen, Z., Aviszus, K., Downing, W., . . . Zhang, G. (2021). 501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to Bamlanivimab in vitro. bioRxiv.

Chicago Style aipamena

Liu, Haolin, et al. "501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro." BioRxiv 2021.

MLA aipamena

Liu, Haolin, et al. "501Y.V2 and 501Y.V3 Variants of SARS-CoV-2 Lose Binding to Bamlanivimab in Vitro." BioRxiv 2021.